Neurotechnology’s Cultural Embedding: How Brain-Computer Interfaces Reflect and Reinforce Extractive Innovation Paradigms

Indigenous epistemologies frame cognitive processes as inherently relational and place-based, challenging the Western paradigm of isolating the brain as a discrete, modifiable unit. The commodification of neurotechnology risks erasing these worldviews, reducing complex cultural understandings of mind and body to mere technical challenges. Moreover, Indigenous communities have long used non-invasive techniques (e.g., plant medicines, communal rituals) to alter consciousness, which are often dismissed as 'primitive' in favor of Silicon Valley’s invasive solutions. The current BCI narrative fails to engage with these alternatives, instead reinforcing a colonial logic of technological supremacy.

The development of BCIs is deeply rooted in Cold War-era military research, particularly DARPA’s programs to restore function to wounded soldiers, which laid the groundwork for today’s civilian applications. The commercialization of neurotechnology mirrors historical patterns of medical innovation, where breakthroughs in prosthetics or pharmaceuticals often originate from wartime needs before trickling down to civilian use. However, unlike past medical technologies, BCIs are being deployed in an era of unchecked corporate power, where patents and proprietary algorithms threaten to monopolize cognitive augmentation. This historical continuity reveals a pattern of extractive innovation, where marginalized groups (e.g., veterans, patients) are often the first test subjects.

Cross-culturally, the emphasis on individual cognitive enhancement through BCIs contrasts with collectivist approaches to knowledge and memory, such as the Māori concept of *whakapapa* (genealogy) or the Ubuntu philosophy of 'I am because we are.' In Japan, the integration of robotics with human cognition (e.g., *kawaii* robotics) reflects a more harmonious, aesthetic-driven approach to human-machine symbiosis, unlike the Western focus on performance and efficiency. Additionally, in parts of South America, traditional healers (*curanderos*) use plant-based entheogens to facilitate communal and spiritual experiences, offering a non-invasive alternative to BCIs for altering consciousness. These diverse frameworks highlight the cultural specificity of 'cognitive enhancement.'

Scientifically, the feasibility of BCIs for music creation is supported by advances in neural decoding and machine learning, which enable real-time translation of brain activity into sound. However, the field is still grappling with challenges such as signal stability, biocompatibility, and the long-term health impacts of invasive implants. Current research is dominated by Western institutions (e.g., Stanford, MIT) and corporations (e.g., Neuralink, Synchron), which may overlook cultural and biological variations in brain function. Moreover, the focus on 'enjoyable' interfaces risks prioritizing user experience over clinical efficacy, particularly for patients with neurological disorders.

Artistically, BCIs open new frontiers for neurofeedback art, where brain activity directly shapes creative expression, challenging traditional notions of authorship and intentionality. Spiritually, the technology raises questions about the nature of consciousness—whether it is a fixed entity or a fluid, emergent property of the brain-machine interface. However, the commercialization of such art risks reducing it to a novelty, stripping it of its potential to interrogate the human condition. Indigenous and Eastern spiritual traditions, which view the mind as interconnected with the universe, offer richer frameworks for exploring these questions than the current techno-utopian narrative.

Future scenarios for BCIs range from utopian visions of democratized cognitive augmentation to dystopian outcomes where neurotechnology exacerbates social stratification, creating a 'cognitive elite' and a marginalized underclass. The rapid pace of innovation outstrips regulatory frameworks, risking scenarios where corporations exploit neurodata for profit or state surveillance. Additionally, the environmental costs of neurotechnology—such as the mining of rare earth minerals for implants—could lead to resource conflicts and ecological collapse. Scenario planning must account for these risks, as well as the potential for BCIs to enable new forms of collective intelligence, such as shared neural networks for global problem-solving.

Marginalized voices—including patients with neurological conditions, disabled communities, and Global South populations—are conspicuously absent from the BCI narrative, despite being the most likely to benefit or suffer from the technology. Neurotechnology is often developed without input from the very communities it aims to serve, reinforcing a top-down, paternalistic model of innovation. For example, individuals with locked-in syndrome or ALS are frequently treated as test subjects rather than co-designers of BCIs. Additionally, the high cost of neurotechnology risks creating a cognitive divide, where only the wealthy can afford augmentation, further marginalizing those with pre-existing inequalities.